Vident Investment Advisory’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-170,329
Closed -$14.8M 1292
2022
Q3
$14.8M Sell
170,329
-4,533
-3% -$476K 0.48% 43
2022
Q2
$19.9M Buy
174,862
+11,893
+7% +$1.37M 0.6% 24
2022
Q1
$21.1M Buy
162,969
+13,816
+9% +$1.99M 0.55% 43
2021
Q4
$26.9M Sell
149,153
-16,171
-10% -$2.8M 0.7% 27
2021
Q3
$24.5M Sell
165,324
-9,138
-5% -$1.4M 0.74% 26
2021
Q2
$26.4M Sell
174,462
-19,742
-10% -$2.75M 0.8% 23
2021
Q1
$25.2M Buy
194,204
+34,834
+22% +$4.47M 0.85% 24
2020
Q4
$19.1M Sell
159,370
-34,633
-18% -$3.4M 0.78% 32
2020
Q3
$14.5M Buy
194,003
+14,448
+8% +$1M 0.72% 29
2020
Q2
$12.7M Buy
179,555
+53,099
+42% +$3.63M 0.67% 33
2020
Q1
$8.29M Sell
126,456
-22,366
-15% -$1.78M 0.54% 50
2019
Q4
$12.2M Sell
148,822
-14,400
-9% -$1.1M 0.75% 32
2019
Q3
$11.8M Buy
163,222
+4,167
+3% +$306K 1.03% 31
2019
Q2
$13.7M Buy
+159,055
New +$12.9M 1.1% 30
2015
Q4
Sell
-16,345
Closed -$508K 705
2015
Q3
$508K Sell
16,345
-321
-2% -$11.5K 0.07% 517
2015
Q2
$628K Buy
16,666
+1,111
+7% +$40.5K 0.08% 354
2015
Q1
$546K Sell
15,555
-414
-3% -$13.6K 0.11% 353
2014
Q4
$529K Buy
+15,969
New +$493K 0.18% 222

Other funds holding OMCL

Vident Investment Advisory's OMCL Position: Q4 2022 in Review

Vident Investment Advisory sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 170,329 shares — an estimated $14.8M sold.

Vident Investment Advisory first reported a position in OMCL in Q4 2014 and held it in 18 quarters. The position peaked at $26.9M in Q4 2021. 328 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Vident Investment Advisory reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 170,329 Omnicell shares in Q4 2022, an estimated $14.8M.
  • Vident Investment Advisory first reported a position in Omnicell in Q4 2014 and held it in 18 quarters.
  • Vident Investment Advisory's Omnicell position peaked at $26.9M in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.